BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
BMY.RT
Delisted
BMY.RT was delisted on the 31st of December, 2020.
616 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 616 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
616
Holding in Top 10
8
Calls
$48M
Puts
$8.03M
Top Buyers
| 1 | +$150M | |
| 2 | +$107M | |
| 3 | +$91.4M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$78.3M |
| 5 |
ACM
Abrams Capital Management
Boston,
Massachusetts
|
+$69.8M |
Top Sellers
No sellers this quarter